ym 09151-2 has been researched along with Acute Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishida, M; Kaneko, S; Kondo, T; Otani, K; Tokinaga, N; Yasui, N | 1 |
| Kaneko, S; Kondo, T; Mihara, K; Nagashima, U; Ono, S; Otani, K; Suzuki, A | 1 |
1 trial(s) available for ym 09151-2 and Acute Disease
| Article | Year |
|---|---|
No relationship between Taq1 a polymorphism of dopamine D(2) receptor gene and extrapyramidal adverse effects of selective dopamine D(2) antagonists, bromperidol, and nemonapride in schizophrenia: a preliminary study.
Topics: Acute Disease; Alleles; Antipsychotic Agents; Benzamides; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Extrapyramidal Tracts; Female; Haloperidol; Humans; Male; Pilot Projects; Polymorphism, Restriction Fragment Length; Receptors, Dopamine D2; Reproducibility of Results; Schizophrenia | 2000 |
1 other study(ies) available for ym 09151-2 and Acute Disease
| Article | Year |
|---|---|
Characteristics and risk factors of acute dystonia in schizophrenic patients treated with nemonapride, a selective dopamine antagonist.
Topics: Acute Disease; Adolescent; Adult; Benzamides; Dopamine Antagonists; Dystonia; Female; Humans; Male; Middle Aged; Prolactin; Prospective Studies; Risk Factors; Schizophrenia; Sex Characteristics | 1999 |